Prospective observational cohort consisting of all adult patients admitted to participating critical care units (ICU and CCU) during the study period, with blood cultures collected as part of their care, and who did not express any objection to participating. For each patient, data will be collected prospectively for each blood culture set collected.
Study Type
OBSERVATIONAL
Enrollment
2,411
no intervention
CHU Brest
Brest, France
CHU Dijon
Dijon, France
CHD La Roche sur Yon
La Roche-sur-Yon, France
CH Le Mans
Le Mans, France
Area under the ROC curve of the predictive performance of the score for predicting bacteremia or fungemia.
Time frame: day 1- day 28
Area under the ROC curve of the diagnostic performance of body temperature to predict bacteremia or fungemia;
Time frame: day 1- day 28
Area under the ROC curve of the diagnostic performance of the Shapiro score for predicting bacteremia or fungemia;
Time frame: day 1- day 28
Proportion of bacteremia or fungemia identified by blood cultures in patients on antibiotic therapy and broad-spectrum antibiotic therapy, and factors associated with these bacteremias or fungemias;
Time frame: day 1- day 28
Comparison of the diagnostic performance of the score in predicting bacteremia or fungemia observed during the first 48 hours of hospitalization to later bacteremias;
Time frame: 48 hours
Descriptive study of the contribution of blood cultures, whatever their results, to the prescription of anti-infectives.
Time frame: day 1- day 28
Efficiency of the new predictive score for blood culture positivity in Intensive Care, as compared with body temperature and Shapiro score, measured by two Incremental Cost-Effectiveness Ratios (ICER): ICER (incremental cost per additional well-detecte
A tree decision model will compare three strategies for predicting positive blood cultures: the new predictive score, body temperature and Shapiro score. Within-trial data will be used to define the model parameters. The model will consider the costs related to the implementation of the strategies, blood cultures, and potential delays in patient management. This will result in the estimation of the two ICERs.
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.
CHU Nantes
Nantes, France
CHR Orléans
Orléans, France
CHU Poitiers
Poitiers, France
CHU Rennes
Rennes, France
CHIU Strasbourg
Strasbourg, France
CHU de Tours
Tours, France
Time frame: less than 1 month